Detalhe da pesquisa
1.
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
Lancet Oncol;
22(8): 1103-1114, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34214495
2.
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
J Neurooncol;
155(3): 297-306, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34689306
3.
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
J Neurooncol;
133(3): 589-594, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28510787
4.
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas.
J Neurooncol;
129(1): 139-46, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27300524
5.
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
J Neurooncol;
126(2): 309-16, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26508094
6.
Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity.
J Neurooncol;
118(1): 147-53, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24574050
7.
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).
J Neurooncol;
118(2): 335-343, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24740196
8.
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
J Neurooncol;
117(1): 93-101, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24449400
9.
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
J Neurooncol;
112(2): 247-55, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23354655
10.
Brainstem glioma: a review.
Curr Neurol Neurosci Rep;
13(5): 346, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23512689
11.
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Neuro Oncol;
25(3): 557-565, 2023 03 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35948282
12.
Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
Cancer;
118(15): 3743-8, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22179954
13.
Lymphomatosis cerebri presenting with orthostatic hypotension, anorexia, and paraparesis.
J Neurooncol;
109(3): 581-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22806340
14.
Metastatic glioblastoma: case presentations and a review of the literature.
J Neurooncol;
107(1): 21-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21964740
15.
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas.
J Neurooncol;
110(2): 237-43, 2012 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22875709
16.
Treatment of brain metastases: chemotherapy.
Curr Oncol Rep;
14(1): 85-90, 2012 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22161303
17.
Secondary CNS myeloma with remission after systemic CNS-penetrating agents.
Neurooncol Adv;
4(1): vdac106, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35892045
18.
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.
Neurooncol Adv;
4(1): vdac123, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36225651
19.
Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus.
Pituitary;
14(2): 194-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19123039
20.
Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.
Radiology;
255(2): 622-8, 2010 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20413772